OBJECTIVE: Malnutrition is common after oesophageal cancer surgery. This study aims to investigate body mass index (BMI) kinetics and the risk factors of malnutrition among 1-year disease-free survivors after radical transthoracic oesophagectomy for cancer.
INTRODUCTION
Oncologic results of oesophageal cancer surgery have been measured in the past in terms of mortality, morbidity, completeness of resection and in overall survival. Current results of multimodal approaches suggest that long-term outcome could be achieved and we now assist to an unexpected increase in numbers of long-term free-disease survivors. In this context, functional status and health-related quality of life (HRQL) have been emphasized as an important oncologic component to be considered regarding the expected 5-year survival rate up to 40% in most surgical series [1] [2] [3] .
Among the several factors affecting HRQL, malnutrition is a common and severe problem both before and after oesophageal cancer surgery. Unintentional weight loss (WL) affects 79% of patients before diagnosis [4] and WL is one of the most pronounced side effects 6 months after surgery [5] . WL is commonly found after oesophagectomy for cancer and should concern nearly half of the patients with an estimated WL between 10 and 15% of the pre-treatment body weight (BW), i.e. at the onset of symptoms [6] [7] [8] [9] [10] [11] . Digestive symptoms such as dysphagia, reflux or delayed gastric emptying could be explained, especially the poor quality of life observed after oesophagectomy [6] [7] [8] . As a result, malnutrition status is a well-documented factor summarizing all the different negative aspects of the postoperative outcome. Recent data from the group of Stockholm suggest that nearly 50% of patients having undergone oesophagectomy had a WL at least 20% of their preoperative weight within 6 months after surgery [6] . Reasons for such WL are complex and multifaceted. Recurrence of the disease, female gender, preoperative WL and preoperative overweight and occurrence of postoperative complications have been independent factors of this malnutrition [6, [9] [10] [11] .
Because risk factors of WL remain unclear, we have conducted this observational study to investigate body mass index (BMI) kinetics and the risk factors of malnutrition among 1-year disease-free survivors after radical transthoracic oesophagectomy for cancer.
PATIENTS AND METHODS

Patients
From a prospective single-institution database, 1-year diseasefree survivors having undergone a R0 transthoracic oesophagectomy between 2000 and 2008 were identified retrospectively. Our database was created in 1989 and is now part of our daily practice. Every surgeons of the department are involved in the database updating. The database was regularly checked by comparison of the French national database of the French Society of Thoracic and Cardiovascular Surgery Epithor. The national review board of the French Society of Thoracic and Cardiovascular Surgery (SFTCVS) assessed the design of this study (no. CERC-SFCTCV-2011-8-7-17-53-41-D4Xa). Because of its retrospective nature, the IRB waived the need for patient consent.
This study group was extracted from a total cohort of 178 patients who underwent an extended transthoracic oesophagectomy for cancer during the same period. The surgical procedure consisted in all cases of a gastric tubulization to substitute the removed oesophagus. Location of the anastomosis was in the chest or in the neck depending on the location of the tumour. Surgical procedure consists in all cases in a single-stage operation including an abdominal and a transthoracic approach resulting in transthoracic oesophagectomy with radical two-field lymphadenectomy.
Among the initial cohort of 178 patients, 60 were excluded from the final analysis for several reasons: (1) for an early recurrence of disease during the first postoperative year (n = 13); (2) because of related postoperative mortality (n = 13) ; (3) because of incomplete resection (R1-R2) (n = 10); (3) for an outcome less than 1 year (n = 21) and (4) because data were missing (n = 3). The remaining 118 patients constituted the material of the present study and represent a homogeneous group of 1-year disease-free survivors. Patients were considered free of disease after a full postoperative check-up including complete body scan and oesophageal endoscopy.
Data were collected retrospectively by reviewing all medical charts of the patients included in the study providing information regarding patients and tumour characteristics, surgical procedures, neoadjuvant treatment, macroscopic completeness of resection and the use of catheter jejunostomy for enteral feeding. A review of the histopathological reports gave further information on tumour location, histological type, tumour stage and microscopic completeness of resection. Patients were excluded if tumour resection was not complete both microscopically and macroscopically. Tumour stage was defined according to the system of the International Union Against Cancer [12] . Adenocarcinomas adjacent to the gastrooesophageal junction were classified according to Siewert's definition [13] .
Body mass index and weight loss assessment
For all the patients, data of weight, length, BMI and WL were obtained by reviewing medical charts. According to the World Health Organization (WHO) guidelines [14] , patients with a BMI ≥ 25 kg/m² for males and females were classified as overweight and patients with BMI of ≥ 30 kg/m² were classified as obese. Patients with BMI of < 18.5 kg/m² were classified as underweight. Patients with a BMI ranging between 18.5 and 24.9 were defined as a normal population.
For each patient, BMI was calculated four times during the study period: (1) in the pre-treatment period, at the onset of symptoms before any treatment ( pre-treatment BMI); (2) during the preoperative period and at the time of surgery ( preoperative BMI); (3) at postoperative six-months (6-months BMI) and (4) at 1-year postoperatively (1-year BMI).
One-year postoperative denutrition was defined as a WL ≥ 15% measured as the ratio between average pre-treatment weight in kilograms and weight in kilograms at 1 year. Accordingly, patients were grouped into two groups: the first group included those who experienced a WL < 15% of the pretreatment BW; the second included those with a WL ≥ 15% of the pre-treatment BW.
Postoperative complications were categorized according to a modified Clavien's classification [15] . Respiratory complications were defined by all medical events concerning lung parenchyma (i.e. atelectasis, pneumonia, acute respiratory distress syndrome (ARDS) in the absence of early surgical complications. Surgical complications included anastomotic leakage, recurrent nerve paralysis, chylothorax, pleural effusion requiring chest tube drainage, empyema and bleeding.
Statistical analysis
Data were analysed using the SPSS 17.0 package (SPSS Inc., Chicago, IL). Results are expressed as mean ± SD or median (range) for quantitative variables and as percentage for qualitative variables. Descriptive statistics are expressed in number and percentage for binary variables and mean and standard deviation with extremes for quantitative variables. Nonparametric data were analysed using Fisher's exact test for 2 × 2 contingency tables and the Mann-Whitney U-test. For parametric data, an unpaired t-test was used for comparison of differences between means in the two groups. Nonparametric test were used when the number of patients were <10. Predictive factors of 1-year body WL were obtained by univariate and multivariate analyses. Logistic regression was used to estimate relative risks of 1-year malnutrition, expressed as odds ratios (ORs) with 95% confidence intervals. Denutrition was considered as a dichotomous outcome (no, WL < 15%; yes, WL ≥ 15%). Adjustments for potential confounding were made in multivariable logistic regression models. Several models were considered.
RESULTS
Among the initial 178 patients, 118 patients were included in this study. The median age was 59 years (range 28-81 years). There were 90 males (76%) and 28 females (24%). Adenocarcinoma was the dominating histological subtype and 75% of the lesions were located in the lower third of the oesophagus. Almost 22% of patients had a locally advanced tumour and nearly 40% of patients had received preoperative neoadjuvant treatment. Table 1 summarizes the main characteristics and clinical details of the 118 patients.
At the onset of symptoms and before any treatment, majority of patients (n = 65, 55%) had a normal pre-treatment BMI. The mean pre-treatment BMI was 24.64 ± 3 and ranged from 16 to 34.5. Among the remaining 53 patients, 36 were considered as overweight, 12 as obese and 5 as underweight. Assessment of BMI kinetics in the study period is presented in Table 2 . Mean pre-treatment BMI was 24.6 ± 4. Among the 118 patients, 24 (20%) have experienced an unintentional preoperative WL before surgery. The mean preoperative BMI felt to 23.5 ± 3 at the moment of surgery. Mean of 6-months and 1-year BMI were 21.7 ± 3 and 21.9 ± 3, respectively.
At postoperative 6-months, 34 (29%) patients have experienced a WL ≥ 15%. One-year WL ≥ 15% of the pre-treatment BW was present in 29 patients (25%): 18 among the 48 patients (37%) with a pre-treatment BMI ≥ 25 and 11 among the 70 patients (15%) with pre-treatment BMI < 25 (P = 0.006). In the study period, WL kinetics was similar between sex genders (Fig. 1) or between patients having received a neoadjuvant therapy (Fig. 2) .
In order to discriminate which factors were associated with a 1-year WL ≥ 15% of the pre-treatment BW, we have conducted a multivariable analysis including adjustments for several variables obtained from univariate analysis (Table 3) . Age, gender, tumour location, histology, neoadjuvant therapy, feeding jejunostomy, preoperative WL, tumour p-stage and occurrence of postoperative complications did not correlate with a 1-year WL ≥ 15% of the pre-treatment BW. Adjustments for potential confounding were made in multivariable logistic regression models. Several models were considered. On the final step of the logistic regression, pre-treatment BMI > 25 was the sole independent prognosticator of such WL (P = 0.039; OR: 2.96 [range 1.06-8.3]).
DISCUSSION
This observational study emphasizes mostly that postoperative denutrition remains a severe and important problem after oesophageal resection for cancer. Our data suggest that severe denutrition, with a 1-year WL ≥ 15% of the pre-treatment BW affect nearly 25% of our long-term and disease-free survivors. Our logistic regression model indicates that overweight and obese patients with a BMI ≥ 25 are the segment population the most exposed to this postoperative malnutrition. The current design of the study based on long-term survivors with exclusion of all hospital deaths introduces irremediably confounding factors that limit the conclusions that can be reached. The first source of errors is related to the fact that our study presents the result of a single-institution database of a homogeneous cohort that probably increases the risk of centre-effect bias compared with a national study cohort as Martin et al. [11] had recently reported in Sweden. The second source of error is that some patients, particularly those who are overweight, might deliberately choose to lose weight, independently of the effect of 29 (25) surgery. The prospective collection of data is likely to reduce the risk of systematic error owing to misclassification. The lack of information about patients' nutritional intake may be a further weakness, but such intake lies in the causal pathway between exposure to surgery and the malnutrition outcome, and should not therefore be considered as a confounding factor. The third source of errors is that WL should be explained by oncologic reasons such as an early recurrence of the disease interfering with the interpretation of the observed results. For these reasons, we have deliberately excluded all patients with incomplete resection. Moreover, we have selected only patient who were considered as 1-year disease-free survivors after complete postoperative work-up. The use of a WL cut-off of 15% of the pre-treatment BW defining important malnutrition was based on previous research [11] . However, we have opted for an evaluation at 1 year rather than 6 months because of the long lasting effect of such denutrition. As a result in our study, BMI index has slightly increased from postoperative 6 months (21.7 ± 3) to 1 year (21.9 ± 3). We acknowledge that the present study was only based on BMI evaluation and surrogate biochemical or haematological markers of malnutrition have not been investigated. However, this is beyond the scope of the present observational study aiming to describe BMI kinetics during the first year after radical oesophagectomy.
Our results suggest that among patients presenting a 1-year WL ≥ 15%, overweight and obese patients are the most exposed subgroup to malnutrition. This risk factor of malnutrition has been also emphasized by Martin et al. [11] where overweight patients with a preoperative BMI > 25 kg/m² were at the risk of malnutrition with a 5-fold increase at 6 months and at 3 years. The reasons for this denutrition in this selected subgroup are complex and multifaceted.
First, the obese population is underestimated in Europe and their nutritional status is likely to be neglected. In fact, obesity is becoming more prevalent, with 10-15% of individuals in Europe fulfilling the criteria of a BMI > 30 kg/m², and these rates are far from those reported in western countries where obesity concern nearly 30% of the population [16] . In this study, only 10% of our population was considered as obese. Because obese patients 
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represent little sub-categories of patients in Europe, less attention has been paid on their nutritional status. This suggests that overweight and obese patients would have benefited from less vigilance nutrition.
The second reason, which is more semantic, stands on the definitions used. In fact, nutritional assessment is generally based on the simple quantitative evaluation of the WL, i.e. the simple quantification of the weight before and after the surgery. However, according to the WHO's definition [14] , the nutritional evaluation should be investigated on the assessment of the WL kinetics, taking into account the period in months of the malnutrition. Patients who are initially considered as overweight, despite a significant WL, most often keep the BMI in the normal range after the WL. As a result, they are wrongly considered as normal patients while they are presenting important signs of clinical malnutrition months before surgery. This was the case in almost 44% of our patients giving evidence that a large part of the malnutrition is underestimated. In this setting, systematic assessment of objective criteria such as value of albumin level would have probably helped to unmask these patients in apparent good general condition. The use of the nutritional risk index also would have been extremely relevant in this setting [16] .
The third reason seems to be associated with the surgical reconstruction. For all the patients, we have opted for a gastric interposition. Gastric transplant is accepted worldwide because of its ease of performance and its relatively good functional results. However, this substitute can result in important digestive discomfort associated with a severe WL [17] . In fact, this substitute can act as a sort of a bariatric surgery. Some authors have used gastrectomy for surgical management of obesity and have concluded that partial gastrectomy significantly reduce weight and fat [18, 19] . WL reported during the first 3-6 months after partial or complete gastrectomy mainly comprises loss of body protein, with the amount depending on the extent of surgery [18] , whereas body fat stores are mainly depleted in the long term [19] . Recently, it has been shown that distal gastrectomy causes a significant decrease of the secretion of Ghrelin hormone involved in appetite [20] . However, there is a huge variance in Ghrelin secretion rate after gastric surgery and the correlation between Ghrelin and WL in overweight patients remains unclear.
The logical answer to this critical postoperative malnutrition should be the systematic use of an enteral feeding nutrition continued during the first months after oesophagectomy to limit the risks of WL. Feeding jejunostomy has been shown to be both effective and cost-efficient in the preoperative period and for long-term support in patients with cancer of the oesophagus [21] [22] [23] [24] [25] . However, most of the reported studies have used enteral nutrition at least 1 month postoperatively. There are no more than 13% of patients that required prolonged feeding jejunostomy more than 1 month after surgery. This is likely to deserve further investigations on the rational of prolonged enteral nutrition for a prolonged period and especially in overweight patients.
CONCLUSION
It appears disappointing that WL and malnutrition are both neglected after oesophagectomy, especially as there are potential opportunities for preventing such losses through an intensified follow-up, including help from experts in clinical nutrition. In our experience, oesophageal cancer surgery seems to act as a bariatric surgery, in particular, in overweight patients who are the most exposed to this induced dramatic WL. Special vigilance programs on the nutritional status of these overweight patients should be the rule. For a more comprehensive view, further investigations are required to specifically investigate the prognostic impact of post-oesophagectomy WL on long-term outcome, taking into account the several facets of the malnutrition problem regarding nutritional status, HRQL and the immunological consequences of such malnutrition. 
